Antti Virkamäki - Concepedia

Author

Antti Virkamäki

Also Known As

A Virkamaki, A Virkamäki, A. Virkamaki, A. Virkamäki, Antti Virkamaki, Antti Virkamäki, Antti Virkamäki, Antti. Virkamäki, S. Fajardo, Virkamäki, Antti

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

University of Helsinki Minerva Foundation Helsinki University Hospital Joslin Diabetes Center University of Mississippi Medical Center

About

Antti Virkamäki is an author at University of Helsinki specializing in medicine, diabetes, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	18	2K
2	Health Sciences	11	11	1.3K
3	Biochemistry	7	7	1K
4	Allergy	2	2	452
5	Social Sciences	1	1	182

Antti Virkamäki

Publications

Citations

H-Index

Page 1

	Year	Citations
Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance Ariel Zisman, Odile D. Peroni, E. Dale Abel, Nature Medicine Insulin ResistanceMetabolic SyndromeMuscle CausesInsulin SignalingMolecular Physiology	2000	751
Effects of Oral and Transdermal Estrogen Replacement Therapy on Markers of Coagulation, Fibrinolysis, Inflammation and Serum Lipids and Lipoproteins in Postmenopausal Women Satu Vehkavaara, Angela Silveira, Tiina Hakala‐Ala‐Pietilä, Thrombosis and Haemostasis Hormonal ContraceptiveImmunologyOral EstradiolGynecologySerum Lipids	2001	270
Intramyocellular Lipid Is Associated With Resistance to In Vivo Insulin Actions on Glucose Uptake, Antilipolysis, and Early Insulin Signaling Pathways in Human Skeletal Muscle Antti Virkamäki, Elena Korsheninnikova, Anneli Seppälä‐Lindroos, Diabetes	2001	256
Carbodiimide as a tissue fixative in histamine immunohistochemistry and its application in developmental neurobiology. Pertti Panula, Olli Häppölä, Matti S. Airaksinen, Journal of Histochemistry & Cytochemistry ImmunologyPeripheral NervePeripheral NervesSocial SciencesNeurobiology Of Disease	1988	182
Increased Glutamine:Fructose-6-Phosphate Amidotransferase Activity in Skeletal Muscle of Patients With NIDDM Hannele Yki‐Järvinen, Marc C. Daniels, Antti Virkamäki, Diabetes	1996	133
Enhanced Polyamine Catabolism Alters Homeostatic Control of White Adipose Tissue Mass, Energy Expenditure, and Glucose Metabolism Eija Pirinen, Teemu Kuulasmaa, Marko Pietilä, Molecular and Cellular Biology Energy ExpenditureMetabolic RemodelingGlucose ToleranceInsulin SignalingOxidative Stress	2007	128
Differential Effects of Oral and Transdermal Estrogen Replacement Therapy on Endothelial Function in Postmenopausal Women Satu Vehkavaara, Tiina Hakala‐Ala‐Pietilä, Antti Virkamäki, Circulation	2000	119
Expression of adipogenic transcription factors, peroxisome proliferator-activated receptor gamma co-activator 1, IL-6 and CD45 in subcutaneous adipose tissue in lipodystrophy associated with highly active antiretroviral therapy Katja Kannisto, Jussi Sutinen, Elena Korsheninnikova, AIDS	2003	118
Insulin and glucosamine infusions increase O-linked N-acetyl-glucosamine in skeletal muscle proteins in vivo Hannele Yki‐Järvinen, Antti Virkamäki, Marc C. Daniels, Metabolism Glucosamine InfusionsO-linked N-acetyl-glucosamineBiochemistrySkeletal MusclePhysiology	1998	113
Activation of the Hexosamine Pathway by Glucosamine<i>in Vivo</i>Induces Insulin Resistance in Multiple Insulin Sensitive Tissues<sup>1</sup> Antti Virkamäki, Marc C. Daniels, Sari Hämäläinen, Endocrinology	1997	95

Page 1